Answers are grounded in this paper and cite their sources.
This review discusses various aspects of protein aggregation and inhibition strategies, emphasizing the use of polymers, which is one of the most promising approaches to combat various aggregation-induced complications in neurodegenerative diseases and protein therapeutics.
No takes yet. Share an insight, caveat, or question.
Rajan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: